Oxogestone

Oxogestone is a progestin medication which was developed by Hoechst AG but was never marketed. It is a synthetic and orally active progestogen, and hence, is an oral progestogen. Oxogestone is related to other progestins such as nomegestrol acetate and promegestone.

Pharmacology

As a progestin, oxogestone is a synthetic analogue of progesterone, a naturally occurring female sex hormone. Progestins are primarily used in hormone replacement therapy for menopausal symptoms, in birth control pills, and in the treatment of gynecological disorders.

Chemistry

Oxogestone, also known as 6-dehydro-17α-hydroxyprogesterone or as 17α-hydroxypregn-4,6-diene-3,20-dione, is a synthetic pregnane steroid and a derivative of progesterone. It is more specifically a derivative of 17α-hydroxyprogesterone, and is a member of the gonane (18-methylnorprogesterone) group of progestins.

History

Oxogestone was developed by the German pharmaceutical company Hoechst AG, which is now part of Sanofi. Despite its development, it was never marketed.

See also

• List of progestogens
• List of progestogen esters

‎

‎ ‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian